INNO News and Press, Harbor Disruptive Innovation ETF From 03/12/23

This is the first fully granted patent of Innocan in the United States The Patent covers Innocan's proprietary cannabis-based pain relief topical This serves as an indication of Innocan's growing intellectual property portfolio Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - March 1...

"Lady", an 11-year-old female dog was presented to Innocan labs suffering from severe autoimmune mediated polyarthritis. Lady was treated with Glycoflex, steroids, and hydrotherapy, but still suffered pain and had difficulty walking more than a few steps. Lady was administered Innocan's liposom...

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - February 16, 2023) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies and owner of a prop...

RGNX is proceeding towards becoming a pillar of the gene therapy space for ocular diseases. However, it will need time to get there. The company is adequately funded for the journey. REGENXBIO Inc. ( RGNX ) is a developer of genetic treatments for eye diseases. Data ...

After dropping more than 40% year to date, shares of Workday finally look appealing enough to buy. Investors turned cautious after the company’s Q1 earnings print, which saw slightly disappointing revenue growth and cautious commentary around deal closings. Still, Workday&#...

Harbor Capital Advisors, Inc. (“Harbor”), today announced that it is adding to its exchange-traded fund (ETF) lineup, bringing a new active and fully transparent Harbor International Compounders ETF (OSEA) to market in early September, upon completion of the registrati...

DoorDash is now lapping tough pandemic comparables with growth decelerating rapidly from the triple-digit level just several quarters back. The company is moving beyond delivering just food which substantially increases its growth runway. Net cash makes up more than 16% of the mar...

Twitter is a valuable asset, and Musk's buyout offer may have been low. Musk might still go through with the deal, and buying at $38 would earn a 42% return in a short time. If Musk backs out, this is a great entry price for a long-term investment. For further details see: ...

Peloton's stock is down 80% in 6 months. As I've been arguing consistently, avoid this name. Peloton doesn't just burn calories. It also burns through cash. A lot of cash. In fact, it burns 79 cents of free cash flow for every $1 of revenue. Peloton is a stock that I've declared t...

Innocap, Inc. Year End Message To Shareholders NEW YORK , Dec. 14, 2020 /PRNewswire/ -- Message from CEO: "As 2020 draws to a close, I take pleasure in reviewing some of our accomplishments in recent months. In October 2020 , through the merger with Uniqu...